RecruitingNot ApplicableNCT06508255

Time-restricted Eating and Cognition

Time-restricted Eating and Cognition (ChronoBEAT)


Sponsor

German Institute of Human Nutrition

Enrollment

35 participants

Start Date

May 17, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate how time-restricted eating (TRE), more specifically TRE at different times (early vs late in the day), influences brain activity, behavior, decision-making, food intake, physical activity, the gut microbiome and metabolic processes. The study intervention procedure is a replication of that described in Peters et al. (2021).


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 70 Years

Inclusion Criteria5

  • right-handed
  • legally competent
  • physically and mentally healthy
  • BMI: 19-35 kg/m²
  • fluent in reading and speaking German

Exclusion Criteria36

  • weight change >5% of body weight during the last 3 months
  • pregnancy or breastfeeding
  • allergies (inclusion possible after consultation with study doctor)
  • history of cardiovascular disease (myocardial infarction, stroke, hypertension, hypotension) in the last year
  • severe psychiatric condition, including drug addiction and depression
  • impaired renal or liver function
  • dementia or other severely debilitating cognitive disease
  • history of or current eating disorders (e.g., Bulimia nervosa, Anorexia nervosa, Orthorexia nervosa, Binge-Eating disorder)
  • chronic diseases (e.g., Morbus Crohn, Colitis Ulcerosa)
  • metabolic disorders (e.g., metabolic syndrome, diabetes type 1 or 2)
  • hormonal imbalances (e.g., thyroid gland diseases)
  • consuming diseases (e.g., cancer, kachexie) in the last 2 years
  • surgical removal (partial removal) of the digestive organs (e.g., gastrectomy) or history of bariatric surgery
  • Autoimmune conditions or current infection
  • Blood clotting disorders (e.g., haemophilia)
  • Severe anemia
  • severe claustrophobia
  • blood donation four weeks prior to study entry
  • glucocorticoid therapy (oral)
  • anticoagulant medication (inclusion possible if medication can be paused)
  • taking medications that require regular eating
  • any medications or supplements known to affect sleep, circadian rhythms, immune activity or metabolism
  • taking weight loss, lipid or glucose-lowering medications (any medications that affects metabolism) i.e. metformin
  • pacemaker or other electrical implant
  • vaccination during the study course or in the two weeks' prior
  • immunosuppressive premedication
  • currently on a diet/fasting regime (or within 1 month)
  • professional athletes
  • nicotine consumption
  • drug abuse
  • alcohol consumption per week more than 14 beers (0,3l)/ wine (0,125l)/ sparkling wine (0,1l)/Schnaps (4cl)
  • shift work
  • poor sleep quality (PSQI score > 10 at medical screening)
  • travel across more than one time zone one month before study or during study period
  • non-removable metallic implants
  • fear of blood draw

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALEarly Time-Restricted Eating

Eat between 8:00 and 16:00 for 2 weeks

BEHAVIORALLate Time-Restricted Eating

Eat between 13:00 and 21:00 for 2 weeks


Locations(1)

German Institute of Human Nutrition (DIfE)

Nuthetal, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06508255


Related Trials